• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Market for Personalized Gene Therapy Treatments for Cancer: Forecasts to 2025

$995.00 – $1,990.00

Clear
SKU: KLI5421818 Category: Biotechnology Market Research Pages: 150
  • Description
  • Table of Contents
  • Latest reports

Description

In the past, cancer treatments could be painful, invasive and damage the patient’s body.   Now there are many novel techniques available for cancer patients that are not as invasive and detrimental to the body as a whole.    Gene therapy is the most prominent new form of these alternative treatments. 
This report, The Market for Personalized Gene Therapy Treatments For Cancer provides a complete review of the market potential for relatively new approach in cancer research, that of changing genes in the place of using a surgical treatment or a drug product.  In essence, gene therapies replace an improper gene with a normal one.  They also might change the response of a gene.   There are many different approaches within gene therapy.
This report discusses those treatments and estimates market size and market potential for personalized medicine using gene therapy. It includes market forecasts for the following types of cancer:
Breast Cancer
Head & Neck
Leukemia
Pancreatic Cancer
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Brain Cancer
Colorectal Cancer
Leukemia Cancer
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Other Cancer
In addition the report provides:
R&D Activities
Discussion of Somatic vs. Germ Line Gene Therapy
Company Profiles
Overview of Gene Therapy
Overall Market Size and Forecast
Cancer Therapeutic Market Totals
Companies considered in this study consist of companies which have  trials Phase I trials through Phase III drug development and have development that is demonstrating efficacy. These include:
Takara Bio, Inc.
Tocagen, Inc.
VBL Therapeutics Ltd.
Chengdu Shi Endor Biological Engineering Technology Co., Ltd.
Cold Genesys, Inc.
Genprex, Inc.
MaxiVax SA
Momotaro-Gene, Inc.
MultiVir, Inc.
OncoSec Medical, Inc.
Sevion Therapeutics, Inc.
SynerGene Therapeutics, Inc.
Ziopharm Oncology, Inc.
Adaptimmune Ltd.
Advantagene, Inc.
Amgen, Inc.
Bellicum Pharmaceuticals, Inc.
BioCancell Ltd.
Blubird Bio
Celgene
Celsion Corporation

Table of Contents

EXECUTIVE SUMMARY

Overview and Scope of Study

Methodology

How Personalized Medicine is Changing the Cancer Market

Market Potential for Gene Therapy in Cancer

GENE THERAPY OVERVIEW

Genetics

Reducing Costs

What is Gene Therapy?

Types of Gene Therapy

Somatic Gene Therapy

Germ Line Gene Therapy

Gene Therapy Applications

Regulation Overview

Orphan Drug Designation Incentives

Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review

Fast Track

Breakthrough Therapy

Accelerated Approval

Priority Review

State ‘Right to Try’ Laws

CANCER AND GENE THERAPY

How has the Cancer Treatment Market Evolved?

Pharmacogenomics

Using Gene Therapy to Treat Cancer

Viral Vectors and DNA Therapies

Curing CancerThe Ultimate Goal

Global Cancer Impact

Gene Therapy and Cancer Development Overview

Development Risk

A Recent Disappointment in Novel Cancer Therapy Development Allovectin-7

Development Programs

Insurance and Reimbursement Issues

GENE THERAPY OUTLOOK IN BLADDER CANCER

Bladder Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

BioCancell Ltd.

Research Activities

Company Background

Cold Genesys, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Bladder Cancer

Potential Market for Gene Therapy in Bladder Cancer

GENE THERAPY OUTLOOK IN BRAIN CANCER

Brain Cancer Overview

Glioblastoma

Neuroblastoma

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Advantagene, Inc.

Research Activities

Company Background

BioCancell Ltd.

Research Activities

Company Background

Celsion Corporation

Research Activities

Company Background

Tocagen, Inc.

Research Activities

Company Background

VBL Therapeutics Ltd.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Brain Cancer

Potential Market for Gene Therapy in Brain Cancer

GENE THERAPY OUTLOOK IN BREAST CANCER

Breast Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

ZIOPHARM Oncology, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Breast Cancer

Potential Market for Gene Therapy in Breast Cancer

GENE THERAPY OUTLOOK IN COLORECTAL CANCER

Colorectal Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

MultiVir, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Colorectal Cancer

Potential Market for Gene Therapy in Colorectal Cancer

GENE THERAPY OUTLOOK IN HEAD & NECK CANCER

Head and Neck Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Chengdu Shi Endor Biological Engineering Technology Co., Ltd

Research Activities

Market Opportunity

Current Market for Treating Head and Neck Cancer

Potential Market for Gene Therapy in Head and Neck Cancer

GENE THERAPY OUTLOOK IN LEUKEMIA

Leukemia Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Bellicum Pharmaceuticals, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Leukemia

Potential Market for Gene Therapy in Leukemia

GENE THERAPY OUTLOOK IN LIVER CANCER

Liver Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

MultiVir, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Liver Cancer

Potential Market for Gene Therapy in Liver Cancer

GENE THERAPY OUTLOOK IN LUNG CANCER

Lung Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Genprex, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Lung Cancer

Potential Market for Gene Therapy in Lung Cancer

GENE THERAPY OUTLOOK IN LYMPHOMA

Lymphoma Overview

Non-Hodgkin’s Lymphoma

Hodgkin’s Lymphoma

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Bellicum Pharmaceuticals, Inc.

Research Activities

Company Background

Sevion Therapeutics, Inc.

Research Activities

Company Background

OncoSec Medical, Inc.

Research Activities

Company Background

Takara Bio, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Lymphoma

Potential Market for Gene Therapy in Lymphoma

GENE THERAPY OUTLOOK IN MELANOMA

Melanoma Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Adaptimmune Limited

Research Activities

Company Background

Amgen, Inc.

Research Activities

Company Background

OncoSec Medical, Inc.

Research Activities

Company Background

ZIOPHARM Oncology, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Melanoma

Potential Market for Gene Therapy in Melanoma

GENE THERAPY OUTLOOK IN OVARIAN CANCER

Ovarian Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Adaptimmune Limited

Research Activities

Company Background

BioCancell Ltd.

Research Activities

Company Background

Celsion Corporation

Research Activities

Company Background

VBL Therapeutics Ltd.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Ovarian Cancer

Potential Market for Gene Therapy in Ovarian Cancer

GENE THERAPY OUTLOOK IN PANCREATIC CANCER

Pancreatic Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Advantagene, Inc.

Research Activities

Company Background

BioCancell Ltd.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Pancreatic Cancer

Potential Market for Gene Therapy in Pancreatic Cancer

GENE THERAPY OUTLOOK IN PROSTATE CANCER

Prostate Cancer Overview

Trends in Incidence and Mortality

Current Approaches to Treatment

Gene Therapy Research Activities

Advantagene, Inc.

Research Activities

Company Background

Momotaro-Gene, Inc.

Research Activities

Company Background

Market Opportunity

Current Market for Treating Prostate Cancer

Potential Market for Gene Therapy in Prostate Cancer

GENE THERAPY AND OTHER CANCERS

Other Cancer Overview

Esophagus Cancer

Multiple Myeloma

Renal Cancer

Thyroid Cancer

Trends in Incidence and Mortality

Esophageal Cancer

Multiple Myeloma

Renal Cancer

Thyroid Cancer

Gene Therapy Research Activities for Other or Unspecific Cancer

Advantagene, Inc.

Research Activities

Company Background

Bluebird Bio

Research Activities

Company Background

MaxiVAX

Research Activities

Company Background

OncoSec Medical, Inc.

Research Activities

Company Background

Sevion Therapeutics, Inc.

Research Activities

Company Background

Takara Bio, Inc.

Research Activities

Company Background

VBL Therapeutics Ltd.

Research Activities

Company Background

Other Companies

GENE THERAPY IN CANCER MARKET SUMMARY AND OUTLOOK

Overview

Cancer Focus Summary

Cancer Gene Therapy Forecast Analysis

Impact of Gene Therapy on Specific Cancer Markets

INDUSTRY PARTICIPANTS AND CONTRIBUTORS

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments – World Market

    $995.00 – $3,990.00
  • Placeholder image

    Worldwide Market for Orthopedic Biomaterials, The

    $2,625.00 – $5,250.00
  • Placeholder image

    Mass Spectrometry in Protein Biomarker Applications – Software, Services, and Instrument Markets

    $995.00 – $5,990.00
  • Placeholder image

    SNP Genotyping and Analysis Markets

    $1,995.00 – $7,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Ultrasound: World Market Analysis, Forecasts to 2018The Market for Home Care Products, Forecasts to 2019, 8th Edition (Wheelchairs,...
Scroll to top